For the quarter ending 2026-03-31, OMER made $9,893K in revenue. $56,060K in net income. Net profit margin of 566.66%.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Product sales, net | 9,893 | - | - | - |
| Cost of product sales | 587 | - | - | - |
| Research and development | 13,358 | 24,290* | 15,995 | 22,009 |
| Selling, general and administrative | 13,369 | 10,387* | 10,397 | 10,345 |
| Total costs and expenses | 27,314 | 34,677 | 26,392 | 32,354 |
| Loss from operations | -17,421 | -34,677* | -26,392 | -32,354 |
| Gain on sale of zaltenibart | - | 59,399* | - | - |
| Gain on early extinguishment of debt-Initial Term Loan | - | 4,259* | - | - |
| Gain on early extinguishment of debt-Convertible Senior Notes2026 | - | -742* | - | - |
| Interest and other income | 1,475 | 1,311* | 616 | 1,241 |
| Loss on early extinguishment of 2026 notes | - | - | 0 | -2,968 |
| Interest expense, net of remeasurement adjustments | 5,894 | 19,050* | -13,355 | 15 |
| Net gain (loss) on change in fair value of financial instruments | 73,146 | 70,802* | -8,822 | 8,207 |
| Income (loss) from continuing operations before income tax expense | 51,306 | 81,301* | - | - |
| Income tax expense | 57 | 503* | - | - |
| Net income (gain) from continuing operations | 51,249 | 80,798* | -21,243 | -25,889 |
| Net income (loss) from discontinued operations, net of tax | 4,811 | 365* | - | - |
| Net income (gain) | 56,060 | 81,162 | -30,917 | -25,424 |
| Basic EPS | 0.78 | 1.236 | -0.47 | -0.43 |
| Diluted EPS | 0.62 | -0.013* | -0.47 | -0.43 |
| Basic Average Shares | 71,917,180 | 65,681,528 | 66,263,992 | 58,585,083 |
| Diluted Average Shares | 90,116,352 | - | - | - |
OMEROS CORP (OMER)
OMEROS CORP (OMER)